Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model
about
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 InfectionHPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.Immunologic Control of Mus musculus Papillomavirus Type 1.New Type of Papillomavirus and Novel Circular Single Stranded DNA Virus Discovered in Urban Rattus norvegicus Using Circular DNA Enrichment and MetagenomicsHPV vaccination for prevention of skin cancer.Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha.Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments.Model systems of human papillomavirus-associated disease.Post-transplantation malignancies: here today, gone tomorrow?Recent advances in preclinical model systems for papillomaviruses.Molecular Mechanisms of Human Papillomavirus Induced Skin CarcinogenesisHuman Papillomavirus and the Stroma: Bidirectional Crosstalk during the Virus Life Cycle and Carcinogenesis.Evolutionary and functional implications of hypervariable loci within the skin virome.The fibronectin/α3β1 integrin axis serves as molecular basis for keratinocyte invasion induced by βHPV.Rodent Papillomaviruses.The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients.The interplay of UV and cutaneous papillomavirus infection in skin cancer development.Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal human papillomaviruses.Care of Mastomys in the laboratory.Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus.Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?
P2860
Q33907700-380DD003-C441-487A-9A3B-C3E675741BA4Q34395881-9F359BC6-A802-49A6-9426-C6CAF3524833Q34822738-81308F43-A54A-4526-8FDD-A3261DE32F79Q35818624-D98FC51A-53D0-4A5C-996E-F1868E38A21EQ35838978-B7C7A691-796A-421E-8567-C582D8E38B5BQ35887782-D85CA7FD-F374-4FAE-8AD9-824843ABF0B3Q36105931-8681D05A-F242-4874-90EB-B6BDC4E71328Q36240497-41B1E651-F8D6-4D49-B696-2BAFD2E0A3D6Q38467270-10F647B7-F50A-48E7-B3D9-0B3DF2B73BB3Q38604326-A74C2523-74DA-432A-866B-643F842D0DD8Q38611709-487DD838-C6CC-4AA2-92BB-EB5E1BACADC4Q39036718-CC20A0E6-E016-4C3C-839D-D58CAF834964Q39434895-597BD935-3C62-4F4C-B90B-6AA3D32A5E5FQ40089345-11CCDC3F-14A8-4314-9B92-63F1A5AE2255Q40334237-761F76D4-0DE7-4AFE-83B8-E0303CAC0C78Q40954858-FD5B767D-7373-4616-A666-25F4AD1DAE75Q46251800-937CEF64-1201-4601-A7CB-2E971FD3D79BQ46271884-AA2162BC-1517-4FDA-AFEC-267CFFA4B3FFQ47098228-73ACD0B8-52A5-48CF-B05F-DEB0E95169ABQ47322093-DCA774CE-B49C-4E2A-9401-A9016F2D751DQ53097662-C545AFEF-7EF3-4393-BC38-1A677BE04786Q54216752-A87B3B23-9E4A-45A0-902D-C238B5809584Q55054189-B84C2C28-6C55-4DEC-ADEA-785ED94B4F9A
P2860
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Protective vaccination against ...... a natural outbred animal model
@ast
Protective vaccination against ...... a natural outbred animal model
@en
Protective vaccination against ...... a natural outbred animal model
@en-gb
Protective vaccination against ...... a natural outbred animal model
@nl
type
label
Protective vaccination against ...... a natural outbred animal model
@ast
Protective vaccination against ...... a natural outbred animal model
@en
Protective vaccination against ...... a natural outbred animal model
@en-gb
Protective vaccination against ...... a natural outbred animal model
@nl
prefLabel
Protective vaccination against ...... a natural outbred animal model
@ast
Protective vaccination against ...... a natural outbred animal model
@en
Protective vaccination against ...... a natural outbred animal model
@en-gb
Protective vaccination against ...... a natural outbred animal model
@nl
P2093
P2860
P3181
P1433
P1476
Protective vaccination against ...... a natural outbred animal model
@en
P2093
Edward K Geissler
Frank Rösl
Ilona Braspenning-Wesch
Ingo Nindl
Kai Schäfer
Martin Müller
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003924
P407
P577
2014-02-01T00:00:00Z